Consistent with research on other cancers, we found that high ALDH1 expression is significantly associated with poor clinical outcomes in serous ovarian cancer patients (n = 439, p = 0.0036). This evidence concerns the gene ALDH1A1 and ovarian serous adenocarcinoma.